Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.41, read 2026-11-05
Ethical passes the values gate
Price148.18 USD
Fair value177.05
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-11Read Markup130.31+13.7% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-02Read Distribution134.25+10.4% to today Markup gives way to Distribution after an 8% rise in 13 weeks
2026-07-02Read Markup124.06+19.4% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Check Point Software Technologies Ltd holds its Markup at $148.18. The statistical read favours the sellers, held for 107 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 107 days
Price at the screen
$148.18
Valuation
16.28 trailing · 14.10 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.47
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
25.26%
Below 33%
Interest-bearing debt is just 25.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
17.00%
Below 33%
Cash held in interest-bearing accounts and securities is 17.0% of assets, under the one-third limit.
Pass
Receivables
32.91%
Below 49%
Money owed to the company is 32.9% of assets, under the 49% limit.
Pass
Revenue purity
3.85%
Below 5%
Only 3.9% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Check Point Software Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 25%, inside the ~33% line, and interest is about 4% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CHKP's ethical verdict changes
Today CHKP passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Cited by BDS movement as an Israeli-founded cybersecurity firm with close ties to Israeli intelligence and military units. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 16% discount to our $177.05 fair value, narrow competitive moat, 1.30% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 16.3% discount to the base estimate.
Where our models see it going: fair-value estimate $177.05, with a range of $159.08 to $265.13, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Steady Security Software But No Real Edge
Picture the quiet firm that still sells the locks on corporate doors long after flashier rivals arrived. Check Point delivers exactly that with its multilevel security tools for cloud and endpoints, yet revenue growth sits at just 5% while the moat stays narrow. A 12 times forward multiple and 38% margins look attractive on paper, and the ethical screen clears without issue, but none of this creates an opportunity worth pursuing when fair value sits well above current levels.
High returns on equity of 38% confirm the business runs efficiently and analyst targets hover near the present price around 142. That combination leaves little margin for error once growth stays this pedestrian. The market already prices the shares close to consensus, so the 30% gap to our fair value does not translate into a compelling case.
Competition in cybersecurity moves quickly and a narrow moat offers limited protection against larger platforms. Slow expansion also raises the risk that earnings multiples compress further rather than expand. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Israel and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CHKP trades on NASDAQ (the company is based in Israel). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Markup$152.11-4.4%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (31 analysts) rates it buy, with a mean price target of $144.
2026-10-25Markup$159.03+15.2%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 15.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (31 analysts) rates it buy, with a mean price target of $144. Since the last review it its composite score eased.
2026-10-18Markup$138.10+6.0%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (31 analysts) rates it buy, with a mean price target of $144.
2026-10-11Markup · changed$130.31-2.9%Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (31 analysts) rates it buy, with a mean price target of $144.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (31 analysts) rates it buy, with a mean price target of $144.
2026-08-25Markup$134.23-2.1%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (31 analysts) rates it buy, with a mean price target of $144.
2026-07-24Markup$137.10+10.5%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (31 analysts) rates it buy, with a mean price target of $144.
2026-07-18Markup$124.06+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (31 analysts) rates it buy, with a mean price target of $144.
2026-07-03Markup$124.06+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$124.06Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
